Generalized epilepsies: current conceptions and therapeutic approaches

The concepts of generalized epilepsy have recently undergone considerable changes: the features of focality in generalized epilepsies and the typical features of idiopathic generalized epilepsies in focal epilepsies have been revealed. The closeness of these forms is also supported by genetic studie...

Full description

Bibliographic Details
Main Author: L R Zenkov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2012-03-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
Online Access:https://nnp.ima-press.net/nnp/article/view/336
id doaj-7a22a121a33a42ecadc5b3816d3f5f23
record_format Article
spelling doaj-7a22a121a33a42ecadc5b3816d3f5f232021-07-29T08:58:32ZrusIMA-PRESS LLCNevrologiâ, Nejropsihiatriâ, Psihosomatika2074-27112310-13422012-03-0141728110.14412/2074-2711-2012-366336Generalized epilepsies: current conceptions and therapeutic approachesL R ZenkovThe concepts of generalized epilepsy have recently undergone considerable changes: the features of focality in generalized epilepsies and the typical features of idiopathic generalized epilepsies in focal epilepsies have been revealed. The closeness of these forms is also supported by genetic studies when one genetic abnormality shows diverse focal and generalized phenotypes in different members of one family. In this connection, the Commission on Classification and Terminology of the International League Against Epilepsy proposes to abandon the identification of the forms of epilepsy on the principle of focal and generalized seizures, by changing it for the notion Tneural network that involves different local and common brain mechanisms in each individual case. These neuropathophysiological concepts give an insight into why the pharmacotherapy based on a model of focal and generalized seizures is ineffective or occasionally even aggravates the disease. The current approach makes it preferential to choose a broad-spectrum drug that is effective in any types of seizures and forms of epilepsy, by taking into account its efficacy, dose titration rate, dosage form, side effects, and cost. Among broad-spectrum agents (valproate (VPA), levetiracetam, lamotrigine, topiramate), the original controlled release dosage forms of VPA (Depakine chrono and Depakine chromosphere) have a priority as first-line drugs for the initial treatment of generalized epilepsies. The paper considers the basic pharmacokinetic and pharmacodynamics properties of the drugs for the treatment of epilepsy and the algorithms of therapy for individual entities of generalized epilepsy.https://nnp.ima-press.net/nnp/article/view/336generalized epilepsiesvalproatecarbamazepinelevetiracetamtopiramatelamotrigine
collection DOAJ
language Russian
format Article
sources DOAJ
author L R Zenkov
spellingShingle L R Zenkov
Generalized epilepsies: current conceptions and therapeutic approaches
Nevrologiâ, Nejropsihiatriâ, Psihosomatika
generalized epilepsies
valproate
carbamazepine
levetiracetam
topiramate
lamotrigine
author_facet L R Zenkov
author_sort L R Zenkov
title Generalized epilepsies: current conceptions and therapeutic approaches
title_short Generalized epilepsies: current conceptions and therapeutic approaches
title_full Generalized epilepsies: current conceptions and therapeutic approaches
title_fullStr Generalized epilepsies: current conceptions and therapeutic approaches
title_full_unstemmed Generalized epilepsies: current conceptions and therapeutic approaches
title_sort generalized epilepsies: current conceptions and therapeutic approaches
publisher IMA-PRESS LLC
series Nevrologiâ, Nejropsihiatriâ, Psihosomatika
issn 2074-2711
2310-1342
publishDate 2012-03-01
description The concepts of generalized epilepsy have recently undergone considerable changes: the features of focality in generalized epilepsies and the typical features of idiopathic generalized epilepsies in focal epilepsies have been revealed. The closeness of these forms is also supported by genetic studies when one genetic abnormality shows diverse focal and generalized phenotypes in different members of one family. In this connection, the Commission on Classification and Terminology of the International League Against Epilepsy proposes to abandon the identification of the forms of epilepsy on the principle of focal and generalized seizures, by changing it for the notion Tneural network that involves different local and common brain mechanisms in each individual case. These neuropathophysiological concepts give an insight into why the pharmacotherapy based on a model of focal and generalized seizures is ineffective or occasionally even aggravates the disease. The current approach makes it preferential to choose a broad-spectrum drug that is effective in any types of seizures and forms of epilepsy, by taking into account its efficacy, dose titration rate, dosage form, side effects, and cost. Among broad-spectrum agents (valproate (VPA), levetiracetam, lamotrigine, topiramate), the original controlled release dosage forms of VPA (Depakine chrono and Depakine chromosphere) have a priority as first-line drugs for the initial treatment of generalized epilepsies. The paper considers the basic pharmacokinetic and pharmacodynamics properties of the drugs for the treatment of epilepsy and the algorithms of therapy for individual entities of generalized epilepsy.
topic generalized epilepsies
valproate
carbamazepine
levetiracetam
topiramate
lamotrigine
url https://nnp.ima-press.net/nnp/article/view/336
work_keys_str_mv AT lrzenkov generalizedepilepsiescurrentconceptionsandtherapeuticapproaches
_version_ 1721250853831049216